Search

everythinglearnresearchcommunity

for

Search:↓

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

Balding hair follicle cells are smaller, grow less well, and need more effort to culture than non-balding cells.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

Polydeoxyribonucleotide (PDRN) may help lighten skin and treat hyperpigmentation.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

A new plant extract from Avicennia marina could potentially be used to treat common hair loss.

FDG PET/CT scans can change cancer treatment plans for dogs.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

Cimetidine did not reduce hair growth in women with hirsutism.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Oral contraceptives may cause hair loss in women.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

PFS might be a delusional disorder with potential to become mass psychogenic illness.